One in vitro study demonstrated that a protein kinase c (PKC) inhibitor, GF109203X, inhibits WNT5A-induced cell migration, invasion, and clonogenicity in A549 and A549/DDP (diammine dichloro platinum) lung cancer cells. This evidence concerns the gene PRRT2 and lung carcinoma.